Coral Chui
崔好
Coral Chui (崔好, Cheryl) is the founder and CEO of Enhe Biotechnology (Bota Bio / 恩和生物), a synthetic biology company she built to make biological experimentation scalable engineering rather than craft dependent on individual expertise . An MIT PhD in medical engineering, she launched the firm with a global operations footprint and brought it into industrial-scale production by 2023, when headcount stood at roughly 200 . In 2025 she secured a strategic partnership with Proya, marking Enhe as the first synthetic biology company to land such a deal with the cosmetics group .
AI-generated — may contain errors, please verify.
Coverage
Is the "ChatGPT Moment" for Bio-Manufacturing Here? | 5Y Talk
From the industry's ups and downs to the inflection point brought by AI, from a "lab crayfish" to the "ChatGPT moment" of bio-manufacturing.
In the Biological World, a Foothold for Physical AI
"In the seven years since Enhe was founded, how has an industrial technology company grown AI capabilities?"
Bota Bio Enhe Biotechnology partners with Proya, becoming first synthetic biology company to secure strategic partnership with Proya
Success is rarely replicable; what matters is finding your own path | 5Y View x Bota Bio x METiS Pharmaceuticals
Cross-disciplinary methodology for entrepreneurship.
Source Code Capital closes fifth RMB fund, raising over 7 billion yuan to back tech innovation and SMEs
Invest early, invest small, invest in tech
